Belizaire, Roger
Wong, Waihay J.
Robinette, Michelle L.
Ebert, Benjamin L. http://orcid.org/0000-0003-0197-5451
Article History
Accepted: 31 January 2023
First Online: 20 March 2023
Competing interests
: B.L.E. has received research funding from Celgene, Deerfield, Novartis and Calico and consulting fees from GRAIL. He is a member of the scientific advisory board of and a shareholder of Neomorph, TenSixteen Bio, Skyhawk Therapeutics and Exo Therapeutics. The other authors have no competing interests.